Selectis Health (GBCS) EBIT Margin (2010 - 2025)

Selectis Health has disclosed EBIT Margin across 12 years of filings, most recently posting 4.09% for Q4 2025.

• EBIT Margin for Q4 2025 came in at 4.09%, down 2451.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 3.78% (down 249.0% YoY), and the FY2025 annual result was 3.78%, down 249.0% from the prior year.
• EBIT Margin came in at 4.09% for Q4 2025 at Selectis Health, down from 2.74% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 20.42% in Q4 2024 to a low of 32.53% in Q4 2023.
• The 5-year median for EBIT Margin is 4.81% (2021), against an average of 6.24%.
• Across the five-year window, EBIT Margin sank 3216 bps in 2021 and soared 5294 bps in 2024, its largest moves.
• Selectis Health's EBIT Margin stood at 11.4% in 2021, then dropped by 16 bps to 13.27% in 2022, then plunged by 145 bps to 32.53% in 2023, then soared by 163 bps to 20.42% in 2024, then slumped by 120 bps to 4.09% in 2025.
• The last three EBIT Margin figures came in at 4.09% (Q4 2025), 2.74% (Q3 2025), and 4.31% (Q2 2025), per Business Quant data.